The long arm of the law gave the drug company Pfizer Inc. a couple of pretty firm slaps Wednesday, one of which will bring close to $1 million to Arizona.
As part of a settlement for a multi-state federal lawsuit, the company has agreed to pay $33 million to 41 different states as punishment for misleading marketing tactics in promoting Geodon, an anti-psychotic drug used to treat schizophrenia.
Arizona's cut: At lease $830,000 according to Attorney General Terry Goddard.
"Companies are not at liberty to pump up their sales by promoting drugs for uses not approved by the FDA," Goddard says in a press release. "These settlements should send a powerful message throughout the pharmaceutical industry."
We Believe Local Journalism is Critical to the Life of a City
Engaging with our readers is essential to Phoenix New Times's mission. Make a financial contribution or sign up for a newsletter, and help us keep telling Phoenix's stories with no paywalls.
Support Our Journalism
The message is probably pretty clear. This settlement is a mere drop in the bucket compared to the record $2.3 billion settlement Pfizer reached with the federal government yesterday, which was the largest corporate penalty in U.S. history
Come on, Terry, you can't get Arizona get a piece of that action?